| Literature DB >> 32013272 |
Daniela Gruľová1, Lucia Caputo2, Hazem S Elshafie3, Beáta Baranová1, Laura De Martino2, Vincent Sedlák4, Zuzana Gogaľová4, Janka Poráčová4, Ippolito Camele3, Vincenzo De Feo2.
Abstract
Searching for new bio-based herbicides is crucial for decreasing chemical pollution, protecting the environment, and sustaining biodiversity. Origanum vulgare is considered a promising source of essential oil with herbicidal effect. The mode of action is not known. The present study focused on (1) comparison of phytotoxic activity of Origanum vulgare EO on monocot (Triticum aestivum and Hordeum vulgare) and dicot species (Lepidium sativum and Sinapis alba); (2) and evaluating other antimicrobial biological activities against phytopatogen bacteria (Clavibacter michiganensis, Pseudomonas syringae pv. phaseolicola, Pseudomonas savastanoi, and Xanthomonas campestris); antifungal activity against Monilinia fructicola, Aspergillus niger, Penicillium expansum, and Botrytis cinerea; cytotoxic activity and antioxidant activity. According to the GC/MS analyses, the EO belongs to the thymol chemotype O. vulgare with its high content of thymol (76%). Germination of all four species was not influenced by EO. The phytotoxic effect was statistically significant in the monocot species, while in the dicot species the opposite was observed-a stimulation effect, which was also statistically significant. Strong biological activity of O. vulgare EO was noted on all phytopatogen bacteria and fungi in the highest dose. Cytotoxic activity showed an IC50 = 50.5 μg/mL. Antioxidant activity showed an IC50 = 106.6 μg/mL after 45 min experimental time. Based on the presented results, it is possible to conclude that thymol chemotype O. vulgare essential oil could be potentially used as a herbicide with selective effects on monocot plant species.Entities:
Keywords: antifungal activity; antimicrobial activity; dicots; monocots; phytotoxicity; thymol chemotype
Mesh:
Substances:
Year: 2020 PMID: 32013272 PMCID: PMC7037002 DOI: 10.3390/molecules25030595
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Identified components in Origanum vulgare EO.
| No. | Name of Compound | KIexp | KI lit | % | Identif. | |
|---|---|---|---|---|---|---|
| 1. | α-pinene | 938 | 936 | 0.2 | KI, MS, S | M |
| 2. | camphene | 951 | 950 | 0.2 | KI, MS | M |
| 3. | sabinene | 976 | 973 | 0.1 | KI, MS | M |
| 4. | β-pinene | 980 | 978 | 0.3 | KI, MS, S | M |
| 5. | α-terpinene | 1016 | 1013 | 0.7 | KI, MS, S | M |
| 6. | p-cymene | 1020 | 1015 | 5.7 | KI, MS, S | M |
| 7. | 1,8-cineole | 1033 | 1024 | 0.6 | KI, MS, S | MO |
| 8. | (Z)-β-ocimene | 1035 | 1029 | T | KI, MS, S | M |
| 9. | γ-terpinene | 1060 | 1051 | 2.5 | KI, MS, S | M |
| 10. | terpinolene | 1088 | 1082 | T | KI, MS, S | M |
| 11. | linalool | 1098 | 1086 | 2.6 | KI, MS, S | MO |
| 12. | camphor | 1121 | 1123 | 0.7 | KI, MS, S | MO |
| 13. | L-trans-pinocarveol | 1130 | 1125 | T | KI, MS | MO |
| 14. | borneol | 1152 | 1150 | 0.8 | KI, MS, S | MO |
| 15. | terpinen-4-ol | 1160 | 1164 | 0.7 | KI, MS | MO |
| 16. | α-terpineol | 1178 | 1176 | 0.4 | KI, MS | MO |
| 17. | carvone | 1217 | 1214 | T | KI, MS, S | MO |
| 18. | carvotanacetone | 1230 | 1220 | T | KI, MS | MO |
| 19. | thymol | 1270 | 1267 | 76.0 | KI, MS, S | MO |
| 20. | carvacrol | 1282 | 1278 | 3.2 | KI, MS, S | MO |
| 21. | eugenol | 1333 | 1331 | 0.1 | KI, MS | MO |
| 22. | α-cubebene | 1354 | 1355 | 0.3 | KI, MS | S |
| 23. | α-gurjunene | 1411 | 1413 | T | KI, MS | S |
| 24. | α-himachalene | 1449 | 1450 | 0.1 | KI, MS | S |
| 25. | humulene | 1454 | 1455 | T | KI, MS | S |
| 26. | allo-aromadendrene | 1461 | 1462 | T | KI, MS | S |
| 27. | β-guaiene | 1490 | 1488 | T | KI, MS | S |
| 28. | valencene | 1494 | 1494 | 0.1 | KI, MS | S |
| 29. | α-muurolene | 1495 | 1496 | T | KI, MS | S |
| 30. | γ-cadinene | 1512 | 1507 | 0.1 | KI, MS | S |
| 31. | calamenene | 1513 | 1517 | T | KI, MS | S |
| 32. | β-cadinene | 1520 | 1526 | 0.4 | KI, MS | S |
| 33. | α-calacorene | 1534 | 1527 | 0.1 | KI, MS | S |
| 34. | elemol | 1539 | 1541 | T | KI, MS | SO |
| 35. | caryophyllene oxide | 1580 | 1578 | 0.4 | KI, MS | SO |
| 36. | globulol | 1583 | 1589 | T | KI, MS | SO |
| 37. | cedrol | 1598 | 1603 | T | KI, MS | SO |
| 38. | γ-eudesmol | 1620 | 1618 | T | KI, MS | SO |
| 39. | allo-aromadendrene epoxide | 1621 | 1623 | 0.1 | KI, MS | SO |
| 40. | tau.cadinol | 1634 | 1633 | T | KI, MS | SO |
| 41. | tau.muurolol | 1635 | 1633 | T | KI, MS | SO |
| 42. | cubenol | 1636 | 1630 | T | KI, MS | SO |
| Total Identified | 96.4 |
T—traces less than 0.1%; KIexp—expected Kovats index predicted by software, KIlit—comparison of Kovats index with literature (Adams; Hochmuth); Identification:, MS—comparison of mass spectra with the literature, S–comparison with external standard, M—monoterpenes, MO—oxygenated monoterpenes, S-sesquiterpenes, SO—oxygenated sesquiterpenes.
Total number and % of germinated seed of model organisms in comparison to control after exposition to particular doses of Origanum vulgare EO.
| Applied Doses of EO (µg/mL) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | 100 | 50 | 25 | 10 | 5 | 2.5 | 1.25 | 0.625 | 0.25 | 0.125 | 0.0625 | |
|
| ||||||||||||
| Numb. GS |
| 22 | 23 | 22 | 25 | 24 | 21 | 24 | 22 | 23 | 27 | 27 |
| % GS |
| 73.33 | 76.67 | 73.33 | 83.33 | 80.00 | 70.00 | 80.00 | 73.33 | 76.67 | 90.00 | 90.00 |
|
| ||||||||||||
| Numb. GS |
| 28 | 27 | 27 | 27 | 30 | 29 | 29 | 30 | 30 | 30 | 30 |
| % GS |
| 93.33 | 90.00 | 90.00 | 90.00 | 100 | 96.67 | 96.67 | 100 | 100 | 100 | 100 |
|
| ||||||||||||
| Numb. GS |
| 9 | 13 | 22 | 17 | 16 | 19 | 17 | 16 | 19 | 13 | 6 |
| % GS |
| 30.00 | 43.33 | 73.33 | 56.67 | 53.33 | 63.33 | 56.67 | 53.33 | 63.33 | 43.33 | 53.33 |
|
| ||||||||||||
| Numb. GS |
| 19 | 23 | 23 | 22 | 22 | 22 | 24 | 18 | 18 | 23 | 21 |
| % GS |
| 63.33 | 76.67 | 76.67 | 73.33 | 73.33 | 73.33 | 80.00 | 60.00 | 60.00 | 76.67 | 70.00 |
Numb. GS—number of germinated seeds; % GS—percentage of germinated seeds; table squares highlighted by lighter grey indicate lower number % of germinated seeds, highlighted by darker grey indicate higher number % of germinated seeds in comparison to control. Total number of treated seeds was 30. Each treatment was triplicated.
Average roots length in cm of particular model organisms in comparison to control after exposition to different doses of Origanum vulgare EO.
| Applied EO Doses [µg/mL] | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cont. | 100 | 50 | 25 | 10 | 5 | 2.5 | 1.25 | 0.625 | 0.25 | 0.125 | 0.0625 | ||
|
| Min |
| 0.6 | 0.5 | 0.3 | 0.5 | 0.6 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Max |
| 7.2 | 6.5 | 10.1 | 6.1 | 10.6 | 5.7 | 5.4 | 4.6 | 4.3 | 5.5 | 5.5 | |
| Mean |
| 3.2 | 3.1 | 3.4 | 3.2 | 2.8 | 2.3 | 1.9 | 1.8 | 1.2 | 1.8 | 2.3 | |
| SD |
| 1.9 | 1.9 | 2.8 | 1.6 | 2.3 | 1.8 | 1.6 | 1.5 | 1.1 | 1.6 | 1.6 | |
| Median |
| 3.3 | 2.8 | 2.5 | 3.1 | 2.1 | 1.6 | 1.9 | 1.2 | 0.7 | 1.2 | 2.5 | |
| Signif. | *** | *** | ** | *** | ** | * | |||||||
|
| Min |
| 0.5 | 2.1 | 1.8 | 0.5 | 0.6 | 0.5 | 0.2 | 0.3 | 0.4 | 0.5 | 1.5 |
| Max |
| 5.8 | 11.2 | 13.2 | 13.1 | 12.0 | 13.1 | 12.8 | 12.5 | 13.0 | 11.0 | 12.3 | |
| Mean |
| 3.6 | 7.5 | 9.0 | 5.7 | 8.4 | 7.2 | 8.2 | 8.3 | 7.9 | 7.1 | 7.6 | |
| SD |
| 1.3 | 2.3 | 3.3 | 3.6 | 3.7 | 3.5 | 3.2 | 3.5 | 3.7 | 2.6 | 2.7 | |
| Median |
| 4.0 | 8.1 | 10.3 | 5.3 | 10.2 | 8.3 | 8.6 | 9.0 | 9.0 | 7.8 | 8.1 | |
| Signif. | * | *** | *** | *** | ** | *** | *** | *** | *** | *** | |||
|
| Min |
| 0.6 | 0.7 | 0.1 | 0.4 | 0.4 | 0.6 | 0.3 | 0.3 | 0.4 | 0.3 | 0.5 |
| Max |
| 3.1 | 6.3 | 4.6 | 6.3 | 5.3 | 5.7 | 3.5 | 4.0 | 6.8 | 4.3 | 3.4 | |
| Mean |
| 1.9 | 3.2 | 1.8 | 3.3 | 3.4 | 3.5 | 1.9 | 1.9 | 2.8 | 2.4 | 2.1 | |
| SD |
| 0.8 | 1.8 | 1.5 | 1.8 | 1.3 | 1.7 | 1.0 | 1.1 | 1.7 | 1.3 | 0.8 | |
| Median |
| 2.1 | 3.5 | 1.7 | 3.4 | 3.5 | 3.7 | 2.0 | 1.7 | 2.7 | 2.3 | 2.1 | |
| Signif. | ** | ** | *** | *** | * | *** | |||||||
|
| Min |
| 0.2 | 0.5 | 0.3 | 0.2 | 0.9 | 1.1 | 0.3 | 0.3 | 1.5 | 0.3 | 0.5 |
| Max |
| 1.8 | 3.2 | 2.7 | 3.8 | 4.8 | 4.0 | 2.40 | 3.2 | 3.5 | 2.5 | 3.2 | |
| Mean |
| 1.1 | 1.9 | 1.7 | 1.9 | 2.8 | 2.5 | 1.7 | 1.9 | 2.4 | 1.5 | 1.8 | |
| SD |
| 0.5 | 0.8 | 0.6 | 1.1 | 0.8 | 0.9 | 0.5 | 0.9 | 0.6 | 0.6 | 0.7 | |
| Median |
| 1.2 | 1.8 | 1.8 | 1.9 | 2.9 | 2.8 | 1.9 | 2.0 | 2.3 | 1.5 | 1.8 | |
| Signif. | *** | * | ** | *** | *** | ** | |||||||
Table square highlighted by lighter grey indicates shorter average roots length in comparison to control, highlighted by darker grey indicates higher average roots length in comparison to control. * - p < 0.05, ** - p < 0.01, *** - p < 0.001. Each treatment was triplicated.
Figure 1Percentage of cell viability after 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Cells were treated with different doses (800–100 µg/mL) of Origanum vulgare EO for 24 h and solvent (DMSO, 0.1%) alone. Data are the mean ± SD of three experiments **** - p < 0.0001.
Figure 2Antibacterial activity of Origanum vulgare EO Bars with different letters for each tested EO dose indicate mean values significantly different at p < 0.05 according to Tukey (B) test. Data are expressed as mean of three replicates ± SD.
Figure 3Antifungal activity of Origanum vulgare EO. Bars with different letters for each tested fungus indicate mean values significantly different at p < 0.05 according to Tukey B test. Data are expressed as mean of three replicates ± SD.
Antioxidant activity of different doses of Origanum vulgare EO. Data are reported as mean ± SD of three replicates. DPPH: 2.2-diphenyl-1-picrylhydrazil.
| Sample/Extract | (µg/mL) | Log (µg/mL) | DPPH (%) after 15 min | DPPH (%) after 30 min | DPPH (%) after 45 min |
|---|---|---|---|---|---|
| CTRL DPPH | 100 ± 2.00 | 100 ± 2.84 | 100.00 ± 3.10 | ||
| Oregano | 3 | 0.477 | 97.61 ± 0.40 | 96.75 ± 0.74 | 95.47 ± 0.92 |
| Oregano | 6 | 0.778 | 88.70 ± 1.34 | 88.20 ± 1.57 | 87.20 ± 1.69** |
| Oregano | 12.5 | 1.097 | 92.31 ± 0.54 | 89.67 ± 0.53 | 87.41 ± 0.79*** |
| Oregano | 25 | 1.398 | 86.22 ± 0.86 * | 82.42 ± 1.35** | 79.06 ± 1.66**** |
| Oregano | 50 | 1.699 | 83.52 ± 8.14**** | 72.64 ± 3.23**** | 68.00 ± 3.15**** |
| Oregano | 100 | 2.000 | 69.59 ± 4.72**** | 58.14 ± 4.46**** | 52.84 ± 4.30**** |
| Oregano | 200 | 2.301 | 46.66 ± 5.07**** | 38.89 ± 4.45**** | 33.80 ± 3.96**** |
* - p < 0.05, ** - p < 0.01, *** - p < 0.001, **** - p < 0.0001. Values followed by different stars are significant according to Tukey’s multiple comparisons test.
Figure 4Percentage of DPPH in solution after 15, 30, and 45 min of treatment with different doses of Origanum vulgare EO.